Streetbeat News

Regulatory

AYRO

AYRO, a US-based electric vehicle manufacturer, has been granted a patent for its user-tailored vehicle seat fabrication technology. This technology allows for customization of vehicle seats based on user preferences, potentially enhancing the user experience and giving AYRO a competitive edge in the EV market.

Portfolio Pulse from Bill Haddad

October 03, 2023 | 12:07 pm

MAIA

MAIA Biotechnology has announced that the FDA has cleared its Investigational New Drug (IND) application for THIO, a first-in-class telomere targeting agent for treating non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 12:03 pm

VIR

Vir Biotechnology, Inc. (NASDAQ:VIR) has been awarded approximately $50 million in new funding by the Biomedical Advanced Research and Development Authority (BARDA) to advance the development of novel monoclonal antibody candidates and delivery solutions for COVID-19 and pandemic preparedness and response.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 12:01 pm

PPH

SPY

The Biden-Harris administration is advancing with plans to negotiate Medicare drug prices in an effort to reduce prescription drug costs for Medicare beneficiaries.

Portfolio Pulse from Charles Gross

October 03, 2023 | 11:56 am

GOOGL

MSFT

Microsoft's CEO, Satya Nadella, has criticized Google's exclusive content deals, which he believes hinder equitable access to essential data needed to advance AI technologies. Nadella's comments were made during his testimony in a US antitrust trial. He highlighted the challenges posed by exclusive deals that tech giants like Google are securing with publishers, which he likened to early distribution deals. Microsoft, a significant player in the AI space, has been investing heavily in AI, including a notable investment in OpenAI's ChatGPT language model.

Portfolio Pulse from Anusuya Lahiri

October 03, 2023 | 11:52 am

SPY

VGK

The Kremlin has responded to a New York Times report suggesting that Russia may be preparing to test an experimental nuclear-powered cruise missile, stating that they don't know where the journalists got this information.

Portfolio Pulse from Charles Gross

October 03, 2023 | 11:48 am

SPRC

SciSparc Ltd. (NASDAQ:SPRC), a clinical-stage pharmaceutical company, has been granted a new patent by The European Patent Office. The patent, titled 'Combinations of Cannabinoids and N-Acylethanolamines', aligns with the company's objective to increase the safety of cannabinoids treatments while maintaining their therapeutic effects. The company has also been granted this patent in the United States, Japan, and Australia.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:34 am

MNMD

Mind Medicine (MindMed) Inc (NASDAQ:MNMD) announced the upcoming presentation of preclinical data of MM-402, its proprietary form of the R-enantiomer of 3,4-Methylenedioxymethamphetamine (MDMA), in a model for autism spectrum disorder (ASD) at the 36th Annual ECNP Congress. The company plans to initiate its first clinical trial of MM-402 in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:31 am

BABA

FXI

KWEB

Alibaba Group Holding Limited (BABA) stock is trading lower in line with the broader indexes iShares China Large-Cap ETF (FXI) and KraneShares Trust KraneShares CSI China Internet ETF (KWEB). The U.S. administration plans to revise regulations restricting the export of AI chips and chipmaking tools to China, which is part of a broader strategy to stabilize U.S.-China relations. Despite U.S. chip sanctions, Alibaba has launched a new AI model and is planning separate IPOs for its different units.

Portfolio Pulse from Anusuya Lahiri

October 03, 2023 | 11:30 am

RNLX

Renalytix has announced that the Centers for Medicare & Medicaid Services has published the price for the company's FDA-authorized KidneyIntelX.DKD test on the Nationwide Clinical Laboratory Fee Schedule at $950.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:12 am